David Young, Pres. Research & Development at Processa Pharmaceuticals, bought PCSA on Jun 15, 2026
Data as of Oct 27
▲ BUY$4.6K2,067 shares at $2.22David Young Pres. Research & DevelopmentPCSA Processa Pharmaceuticals, Inc.
- Traded
- Jun 15, 2026
- Disclosed
- Jun 16, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PCSA since disclosure
−12.9%
Similar stocks (XLV) since disclosure
+17.2%
XLV — its sector index fund
Change in closing price from Jun 16, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
- Not enough evidence · In past tests: 5.6 percentage points better than similar stocks over 3 months · 5,663 tries